Daniel L. Kacian

Chief Tech/Sci/R&D Officer at Gen-Probe, Inc.

77 year

Consumer Services

Health Technology

Profile

Daniel L.
Kacian is currently the Chief Scientist & Executive Vice President at Gen-Probe, Inc. He received his undergraduate degree from Case Western Reserve University and his graduate and doctorate degrees from the University of Illinois.
He also received a doctorate degree from the University of Miami in 1978.

Daniel L. Kacian active positions

Companies	Position	Start
Gen-Probe, Inc. Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA.	Chief Tech/Sci/R&D Officer	01/01/1985

All active positions of Daniel L. Kacian

Training of Daniel L. Kacian

University of Illinois	Doctorate Degree
University of Miami	Doctorate Degree
Case Western Reserve University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Daniel L. Kacian's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Gen-Probe, Inc. Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA.	Health Technology